| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $998,229 ) |
| | 2025 | 2025 | HAWAII BIOTECH, INC. | 650 IWILEI RD | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI120388 | Chikungunya Recombinant Subunit Vaccine | 000 | 6 | NIH | 11/18/2024 | $998,229 |
|
| Issue Date FY: 2024 ( Subtotal = $1,375,238 ) |
| | 2024 | 2024 | HAWAII BIOTECH, INC. | 650 IWILEI RD | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI120388 | Chikungunya Recombinant Subunit Vaccine | 000 | 5 | NIH | 12/22/2023 | $918,090 |
| | 2024 | 2024 | HAWAII BIOTECH, INC. | 650 IWILEI RD | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R43AI174478 | Novel TLR-4 Agonists as Vaccine Adjuvants | 000 | 2 | NIH | 4/4/2024 | $204,860 |
| | 2024 | 2024 | HAWAII BIOTECH, INC. | 650 IWILEI RD | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R43AI172555 | Development of a Cross-Protective New World Encephalitic Alphavirus Subunit Vaccine | 000 | 2 | NIH | 2/16/2024 | $203,325 |
| | 2024 | 2024 | HAWAII BIOTECH, INC. | 650 IWILEI RD | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI120388 | Chikungunya Recombinant Subunit Vaccine | 001 | 5 | NIH | 1/16/2024 | $48,963 |
| | 2024 | 2021 | HAWAII BIOTECH, INC. | 650 IWILEI RD | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI120388 | Chikungunya Recombinant Subunit Vaccine | 002 | 4 | NIH | 6/10/2024 | $0 |
| | 2024 | 2021 | HAWAII BIOTECH, INC. | 650 IWILEI RD | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI118017 | Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses | 000 | 5 | NIH | 4/23/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $407,749 ) |
| | 2023 | 2023 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R43AI174478 | Novel TLR-4 Agonists as Vaccine Adjuvants | 000 | 1 | NIH | 5/2/2023 | $203,485 |
| | 2023 | 2023 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R43AI172555 | Development of a Cross-Protective New World Encephalitic Alphavirus Subunit Vaccine | 001 | 1 | NIH | 7/14/2023 | $0 |
| | 2023 | 2023 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R43AI172555 | Development of a Cross-Protective New World Encephalitic Alphavirus Subunit Vaccine | 000 | 1 | NIH | 3/7/2023 | $204,264 |
|
| Issue Date FY: 2021 ( Subtotal = $1,876,712 ) |
| | 2021 | 2021 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI120388 | Chikungunya Recombinant Subunit Vaccine | 000 | 4 | NIH | 3/19/2021 | $1,000,000 |
| | 2021 | 2021 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI118017 | Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses | 000 | 5 | NIH | 7/21/2021 | $876,712 |
|
| Issue Date FY: 2020 ( Subtotal = $2,373,792 ) |
| | 2020 | 2020 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI120388 | Chikungunya Recombinant Subunit Vaccine | 001 | 3 | NIH | 6/19/2020 | -$148,154 |
| | 2020 | 2020 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI118017 | Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses | 001 | 3 | NIH | 7/27/2020 | $0 |
| | 2020 | 2020 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI118017 | Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses | 000 | 3 | NIH | 6/24/2020 | $389,739 |
| | 2020 | 2020 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI120388 | Chikungunya Recombinant Subunit Vaccine | 000 | 3 | NIH | 4/17/2020 | $1,000,000 |
| | 2020 | 2020 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI120388 | Chikungunya Recombinant Subunit Vaccine | 002 | 3 | NIH | 9/2/2020 | $148,154 |
| | 2020 | 2020 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI118017 | Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses | 002 | 4 | NIH | 7/29/2020 | $984,053 |
| | 2020 | 2017 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R43AI120388 | Chikungunya Recombinant Subunit Vaccine | 000 | 2 | NIH | 12/10/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $839,920 ) |
| | 2019 | 2019 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI118017 | Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses | 002 | 3 | NIH | 8/12/2019 | $0 |
| | 2019 | 2019 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI118017 | Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses | 001 | 3 | NIH | 8/7/2019 | $839,920 |
| | 2019 | 2016 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI118017 | Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses | 000 | 2 | NIH | 5/28/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2016 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R44AI118017 | Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses | 000 | 2 | NIH | 2/15/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $1,900,303 ) |
| | 2017 | 2017 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R43AI120388 | Chikungunya Recombinant Subunit Vaccine | 000 | 2 | NIH | 5/30/2017 | $300,000 |
| | 2017 | 2017 | HAWAII BIOTECH, INC. | 650 IWILEI RD STE 204 | HONOLULU | HI | 96817-5318 | HONOLULU | USA | R01AI104586 | IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors | 000 | 6 | NIH | 4/20/2017 | $1,600,303 |
|
| Issue Date FY: 2016 ( Subtotal = $2,826,193 ) |
| | 2016 | 2016 | HAWAII BIOTECHNOLOGY GROUP, INC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R44AI118017 | Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses | 000 | 2 | NIH | 3/31/2016 | $956,757 |
| | 2016 | 2016 | HAWAII BIOTECHNOLOGY GROUP, INC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R43AI120388 | Chikungunya Recombinant Subunit Vaccine | 000 | 1 | NIH | 7/22/2016 | $300,000 |
| | 2016 | 2016 | HAWAII BIOTECHNOLOGY GROUP, INC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R01AI104586 | IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors | 000 | 5 | NIH | 4/1/2016 | $1,569,436 |
|
| Issue Date FY: 2015 ( Subtotal = $2,750,095 ) |
| | 2015 | 2015 | HAWAII BIOTECHNOLOGY GROUP, INC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R01AI104586 | IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors | 000 | 4 | NIH | 3/27/2015 | $1,593,546 |
| | 2015 | 2015 | HAWAII BIOTECHNOLOGY GROUP, INC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R44AI118017 | Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses | 000 | 1 | NIH | 4/3/2015 | $1,156,549 |
|
| Issue Date FY: 2014 ( Subtotal = $2,654,695 ) |
| | 2014 | 2014 | HAWAII BIOTECHNOLOGY GROUP, INC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R01AI104586 | IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors | 002 | 3 | NIH | 3/24/2014 | $1,528,431 |
| | 2014 | 2013 | HAWAII BIOTECHNOLOGY GROUP, INC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R01AI104586 | IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors | 000 | 2 | NIH | 1/8/2014 | $1,126,264 |
|
| Issue Date FY: 2013 ( Subtotal = $1,395,173 ) |
| | 2013 | 2013 | HAWAII BIOTECHNOLOGY GROUP, INC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R01AI104586 | IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors | 002 | 2 | NIH | 1/8/2014 | $1,126,264 |
| | 2013 | 2013 | HAWAII BIOTECHNOLOGY GROUP, INC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R43AI098229 | DEVELOPMENT OF A RECOMBINANT SUBUNIT VACCINE FOR CCHF | 000 | 2 | NIH | 5/13/2013 | $268,909 |
|
| Issue Date FY: 2012 ( Subtotal = $261,990 ) |
| | 2012 | 2012 | HAWAII BIOTECHNOLOGY GROUP, INC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R43AI098229 | DEVELOPMENT OF A RECOMBINANT SUBUNIT VACCINE FOR CCHF | 000 | 1 | NIH | 6/27/2012 | $261,990 |
|
| Issue Date FY: 2011 ( Subtotal = $993,477 ) |
| | 2011 | 2011 | HAWAII BIOTECHNOLOGY GROUP, INC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R44AI055225 | RECOMBINANT SUBUNIT VACCINE FOR TICK-BORNE ENCEPHALITIS | 000 | 5 | NIH | 7/20/2011 | $993,477 |
|
|
